VRCI
Verde Science Inc. VRCI
  • Home
  • About
    • About Verde Science
    • Canadian Market
    • Corporate Information
    • Disclaimer
  • Team
    • Directors & Management
  • Product
    • Medicinal Marijuana
  • News
    • News Releases
    • News in Videos
    • News in Print
    • Media Contact
  • Investors
    • Stock Quote – VRCI OTCQB
    • Filings / Financials
    • Corporate Information
  • Contact
    • Contact Information
    • Request for Information
Slide background
Slide background
Slide background

News Releases

October 19, 2015

Renown doctor to Lead Verde Science's Huntington Disease Study

LAS VEGAS, Oct. 19, 2015 (GLOBE NEWSWIRE) -- (VRCI) Verde Science, Inc., is a leading Pharmaceutical Research and Development Company that maintains a strong collaboration with leading scientists and pharma companies to create and test pharmaceutical formulations for optimal dosage and delivery mechanisms.…
Read more →
October 12, 2015

Verde Science to Sponsor/Present at the Huntington Study Group Annual Conference

LAS VEGAS, NV / ACCESSWIRE / October 12, 2015 / (OTCQB:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabis-based prescription medicines to meet patients’ needs for a wide range of medical conditions, is pleased to announce it will…
Read more →
October 9, 2015

Verde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon's Disease

LAS VEGAS, Oct. 9, 2015 (Globe Newswire) – Verde Science, Inc. (VRCI), a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients' needs for a wide range of medical conditions, is pleased to announce that along with…
Read more →
June 1, 2015

Verde Science Appoints International Banker Manfred A. Schauer

Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science Inc., a pharmaceutical research and development company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the appointment of Manfred…
Read more →
May 20, 2015

Verde Science Adds Lawyer, Bradley J. Dixon, J.D. to the Board of Directors

Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing effective treatments for contemporary health issues, with an initial focus on developing cannabinoid-based prescription medicines is pleased to announce the appointment…
Read more →
May 12, 2015

Verde Science Appoints New Chief Financial Officer with Pharmaceutical Sector Experience

Las Vegas NV / May 12, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients’ needs for a wide range of medical conditions is pleased to announce the appointment of…
Read more →
May 4, 2015

Verde Science Adds John M. E. Percival to the Head of Strategic Development and Member of Board of Directors

Las Vegas NV / May 4, 2015 (VRCI-OTCQB) Verde Science, Inc. a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions is pleased to announce the appointment of John M.…
Read more →
April 10, 2015

Verde Science Adds Shantesh Hede, Ph.D. as Director of Product Development

Las Vegas NV / April 10, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh…
Read more →
April 8, 2015

Verde Science Signs Research and Development Pact with Institute of Chemical Technology

Las Vegas NV / April 8, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the execution of a…
Read more →
March 13, 2015

Verde Science Provides an Investor Update for Shareholders and Investors

Las Vegas NV / March 13, 2015 / Verde Science, Inc., (VRCI-OTCQB) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant…
Read more →
  • News Releases
  • News in Videos
  • News in Print
  • Media Contact

Sitemap

  • Home
  • About
    • Canadian Market
    • Disclaimer
  • Team
    • Directors & Management
  • Product
    • Medicinal Marijuana
  • News
    • News Releases
    • News in Videos
    • News in Print
    • Media Contact
  • Investors
    • Stock Quote – VRCI OTCQB
    • Filings / Financials
  • Contact
    • Contact Information
    • Request for Information

Contact Information

Verde Science Inc.

Corporate Contact Information
Harp Sangha, Chairman
Tel: 1-604-825-1309
1-702-595-2247
Email: hsangha@verdescienceinc.com